chr17-73348607-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001144952.2(SDK2):c.6157G>A(p.Asp2053Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000967 in 1,612,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000098 ( 0 hom. )
Consequence
SDK2
NM_001144952.2 missense
NM_001144952.2 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 7.72
Genes affected
SDK2 (HGNC:19308): (sidekick cell adhesion molecule 2) The protein encoded by this gene is a member of the immunoglobulin superfamily. The protein contains two immunoglobulin domains and thirteen fibronectin type III domains. Fibronectin type III domains are present in both extracellular and intracellular proteins and tandem repeats are known to contain binding sites for DNA, heparin and the cell surface. This protein, and a homologous mouse sequence, are very similar to the Drosophila sidekick gene product but the specific function of this superfamily member is not yet known. Evidence for alternative splicing at this gene locus has been observed but the full-length nature of additional variants has not yet been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2846092).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SDK2 | NM_001144952.2 | c.6157G>A | p.Asp2053Asn | missense_variant | 44/45 | ENST00000392650.8 | |
SDK2 | XM_011524914.3 | c.6100G>A | p.Asp2034Asn | missense_variant | 43/44 | ||
SDK2 | XM_011524915.3 | c.6157G>A | p.Asp2053Asn | missense_variant | 44/46 | ||
SDK2 | XM_047436313.1 | c.6100G>A | p.Asp2034Asn | missense_variant | 43/45 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SDK2 | ENST00000392650.8 | c.6157G>A | p.Asp2053Asn | missense_variant | 44/45 | 5 | NM_001144952.2 | P1 | |
SDK2 | ENST00000424778.1 | c.3628G>A | p.Asp1210Asn | missense_variant | 26/27 | 5 | |||
SDK2 | ENST00000410094.5 | n.1230G>A | non_coding_transcript_exon_variant | 9/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152256Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
13
AN:
152256
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000642 AC: 16AN: 249314Hom.: 0 AF XY: 0.0000667 AC XY: 9AN XY: 134880
GnomAD3 exomes
AF:
AC:
16
AN:
249314
Hom.:
AF XY:
AC XY:
9
AN XY:
134880
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000979 AC: 143AN: 1460236Hom.: 0 Cov.: 31 AF XY: 0.0000909 AC XY: 66AN XY: 726354
GnomAD4 exome
AF:
AC:
143
AN:
1460236
Hom.:
Cov.:
31
AF XY:
AC XY:
66
AN XY:
726354
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152256Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74388
GnomAD4 genome
AF:
AC:
13
AN:
152256
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.6157G>A (p.D2053N) alteration is located in exon 44 (coding exon 44) of the SDK2 gene. This alteration results from a G to A substitution at nucleotide position 6157, causing the aspartic acid (D) at amino acid position 2053 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at